recently
National Fund for the Development of Small and Medium-sized Enterprises
Announced the successful completion of the sixth batch of sub-fund initiation and establishment tasks
Tonghe Yucheng is the sixth batch of sub-fund management institutions
It has been completed with the national small and medium-sized enterprises
Contracting and establishment of the Development Fund
It was established in Hisai
Hefei Tonghe Phase IV Equity Investment Partnership
(Limited Partnership)
Tens of billions of scale, strong alliances
Founded in 2012 and focusing on the field of medical health and life sciences, Tonghe Yucheng is currently managing a number of US dollar funds and RMB funds, with a cumulative management scale of more than 10 billion yuan.
The first scale of the fund set up in Feixi reached 1 billion yuan, which was jointly established by Tonghe Yucheng and the National SME Development Fund, Anhui Life and Health Industry Theme Investment Fund, Huzhou Nanxun Talent Industry Group, Kefu Medical Technology and other well-known investment institutions. It is the second sub-fund established in Feixi as a theme investment fund for the life and health industry of Anhui Province.
The fund will focus on investing in start-ups with core technical barriers, rich product pipelines under development, and strong team strength, and help enterprises grow rapidly through a combination of direct investment and incubation, which will "build momentum and empower" for the development of Feixi's big health industry.
A new engine for the development of Feixi's health industry
In recent years, based on its own resource endowment, Feixi has cultivated and expanded the three major new industries of new energy vehicles + photovoltaics, high-end intelligent manufacturing, and industry-university-research integration, and developed new quality productivity in Feixi. After years of hard work, Feixi's biomedical industry has gradually changed from "free growth" to "agglomeration". At present, the county has formed a biomedical industry cluster led by a number of large-scale enterprises with advanced layout and leading innovation, such as Yifan Pharmaceutical, Enright Pharmaceutical, and Lianchuang Biotechnology, and driven by a number of growth enterprises with distinctive characteristics and forward-looking R&D such as Ruihua Pharmaceutical, Licheng Pharmaceutical, and Hecheng Biotechnology.
Yifan Pharmaceutical, the head enterprise of Feixi health industry cluster
The establishment of the biomedical fund is another important layout for Feixi to promote the development of the biomedical industry. Through the substantive operation of the fund, Feixi will further expand its global vision in the field of medical health and life sciences, enhance its professional capabilities, and launch a new engine for the innovation and development of Feixi's biomedicine.
2023 Feixi Excellent Fund Management Institution